Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    14 days ago
    No Change Detected
  2. Check
    21 days ago
    No Change Detected
  3. Check
    29 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T16:25:05.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T05:50:25.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This is a minor UI/metadata change with no impact on study details.
    Difference
    0.1%
    Check dated 2026-02-13T17:26:55.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.0 to v3.4.1. No changes to study content or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-02-06T11:27:12.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0. This is a minor template/version update that does not affect study details.
    Difference
    0.1%
    Check dated 2026-02-05T11:20:45.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    Added a Show glossary control and updated page metadata to Revision: v3.4.0. Removed older labels such as Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-29T06:28:21.000Z thumbnail image

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.